Figure 6. Activity profiling of confirmed positives toward a panel of cancer cell lines.

Summary of potency assessment of 21 confirmed positives toward a panel of 13 cancer cell lines in absence of resveratrol or with 30 or 80 µM resveratrol co-treatment. Heat map representation of IC₅₀ values in Alamar Blue-based viability assay of A) 8 agonists and B) 13 antagonists in absence of resveratrol or with 30 or 80 µM resveratrol co-treatment. The triangle symbolizes the increasing concentration in resveratrol.